Old Web
English
Sign In
Acemap
>
Paper
>
ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment
ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment
2016
James W. Purcell
Jonathan A. Hickson
Sonia G. Tanlimco
Melvin Fox
Debra T. Chao
Eric D. Hsi
Mien Sho
Rick Powers
Kelly Foster-Duke
Thomas McGonigal
Tamar Uziel
S. Kumar
Josue Samayoa
K Longenecker
Dominic W Lai
Diane Hollenbaugh
Daniel E. H. Afar
S. Iyer
Susan E. Morgan-Lappe
Kurt C. Gish
Keywords:
Immunology
Tumor microenvironment
Antibody-drug conjugate
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]